Compare Bio Protocol (BIO) vs Symbiosis (SIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Symbiosis — how do they compare? Bio Protocol trades at Rp443.05 (market cap Rp1T, Rp162,69M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Bio Protocol is far larger — about 29342.7× Symbiosis's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Symbiosis for 13 Days on average.
| BIO | SIS | |
|---|---|---|
Market Cap | Rp1T | Rp34,08M |
Volume (24h) | Rp162,69M | Rp2,71M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 18 Days | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and high circulating supply utilization at 98%. The token exhibits a short average hold time of 13 days, suggesting active trading but potentially weak long-term holder confidence. No recent protocol updates or significant ecosystem developments have been recorded, indicating stagnant project momentum.
Overall outlook remains cautious due to low market cap and limited fundamental catalysts. Key opportunities include potential ecosystem growth if development resumes, while major risks involve low liquidity, high volatility typical of small-cap tokens, and regulatory uncertainty in the crypto space.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Symbiosis
Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →
